5326 - 5350 of 8816 Results
Title
Year
-
OPENTitle: Five-Year Longitudinal Trajectories of Non-Motor Symptoms in Relation to Baseline Dopaminergic Decline in Parkinson’s DiseaseJournal Name: Brain DisordersPublisher: Elsevier BVVol: 20Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.dscb.2025.100288Best OA location URL: https://doi.org/10.1016/j.dscb.2025.100288Citation Count: 0
-
OPENTitle: Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 480Issue #: 1Start Page: 78End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2010.06.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2943649Citation Count: 199
-
OPENTitle: Predicting behavioral variant frontotemporal dementia with pattern classification in multi-center structural MRI dataJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 656End Page: 662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.001Best OA location URL: https://doi.org/10.1016/j.nicl.2017.02.001Citation Count: 73
-
OPENTitle: Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentrationJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 9Issue #: 1Start Page: 1816641End Page: 1816641Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/20013078.2020.1816641Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1080/20013078.2020.1816641Citation Count: 122
-
OPENTitle: Crohn’s and Parkinson’s Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex VivoJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page: 794End Page: 800Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11481-020-09909-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-020-09909-8.pdfCitation Count: 19
-
OPENTitle: Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1632End Page: 1642Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27404Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27404Citation Count: 15
-
RESTRICTEDTitle: Frontotemporal dementia as the presenting phenotype of p.A53T mutation carriers in the alpha-synuclein geneJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 35Issue #:Start Page: 82End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.12.002Citation Count: 29
-
OPENTitle: Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s DiseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0097-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0097-0Citation Count: 73
-
RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
-
RESTRICTEDTitle: Concurrent regulation of the transcription factors Nrf2 and ATF4 mediates the enhancement of glutathione levels by the flavonoid fisetinJournal Name: Biochemical PharmacologyPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 1816End Page: 1826Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bcp.2013.04.010Citation Count: 81
-
RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 39
-
OPENTitle: Use of β-adrenoreceptor drugs and Parkinson’s disease incidence in women from the French E3N cohort studyJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251330993Best OA location URL: https://doi.org/10.1177/1877718x251330993Citation Count: 0
-
OPENTitle: Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0426-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0426-8Citation Count: 87
-
OPENTitle: Investigation of the genetic aetiology of Lewy body diseases with and without dementiaJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae190Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae190/58033276/fcae190.pdfCitation Count: 2
- Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter2015OPENTitle: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence ReporterJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 5Start Page: 1188End Page: 1197Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/cb5010417Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9927027Citation Count: 55
-
OPENTitle: Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluidJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0055-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-015-0055-2Citation Count: 39
-
OPENTitle: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synucleinJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8429263Citation Count: 16
-
OPENTitle: PBMCpedia: a harmonized PBMC scRNA-seq database with unified mapping and enhanced celltype annotationJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/nar/gkaf1245Best OA location URL: https://academic.oup.com/nar/advance-article-pdf/doi/10.1093/nar/gkaf1245/65488636/gkaf1245.pdfCitation Count: 0
-
OPENTitle: Deep Learning and fMRI-Based Pipeline for Optimization of Deep Brain Stimulation During Parkinson’s Disease Treatment: Toward Rapid Semi-Automated Stimulation OptimizationJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 12Issue #:Start Page: 589End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2024.3448392Best OA location URL: https://doi.org/10.1109/jtehm.2024.3448392Citation Count: 5
-
OPENTitle: Linear ubiquitination induces NEMO phase separation to activate NF-κB signalingJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 6Issue #: 4Start Page: e202201607End Page: e202201607Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202201607Best OA location URL: https://www.life-science-alliance.org/content/lsa/6/4/e202201607.full.pdfCitation Count: 28
-
OPENTitle: From rodents to humans: Conserved codistribution of dopaminergic with serotonergic neurons in the dorsal raphe nucleus and their molecular characterizationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 217Issue #:Start Page: 107173End Page: 107173Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107173Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107173Citation Count: 0
-
RESTRICTEDTitle: Improving anxiety in Parkinson's disease: A cautionary tale about mobile health technologiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 73Issue #:Start Page: 50End Page: 51Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.010Citation Count: 6
-
OPENTitle: Site-specific neuronal and motor effects of short-term intermittent burst deep brain stimulation in non-human primatesJournal Name: Brain StimulationPublisher: Elsevier BVVol: 18Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2025.05.009Best OA location URL: https://www.brainstimjrnl.com/action/showPdf?pii=S1935861X25001135Citation Count: 0
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 30
-
OPENTitle: Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluorJournal Name: Current Protocols in Chemical BiologyPublisher: WileyVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpch.45Citation Count: 6